167 related articles for article (PubMed ID: 35840164)
21. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
[TBL] [Abstract][Full Text] [Related]
22. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
26. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
Bahaeldein E; Brassill MJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
[TBL] [Abstract][Full Text] [Related]
27. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
Perez Lana M; Demayo S; Monastero A; Nolting M
Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
[TBL] [Abstract][Full Text] [Related]
28. Postmenopausal androgen secreting ovarian tumour: pathophysiological implications; a case report.
Pérez A; Calaf J; Webb SM; Prat J; de Leiva A
Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):97-105. PubMed ID: 2107106
[TBL] [Abstract][Full Text] [Related]
29. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
[TBL] [Abstract][Full Text] [Related]
31. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic removal of virilizing hilar cell tumor in a postmenopausal patient.
Silva PD; Sorensen ML; Reynertson R; Virata RL; Mahairas GH
J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):499-502. PubMed ID: 9224588
[TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
34. Virilization due to androgen hypersecretion in a patient with ovarian leydig cell tumor: diagnostic and psychosocial implications.
Juniarto AZ; Setiawati BA; Ediati A; van der Zwan YG; Looijenga LH; de Jong FH; Dessens A; Drop SL; Faradz SM
Acta Med Indones; 2013 Apr; 45(2):130-5. PubMed ID: 23770793
[TBL] [Abstract][Full Text] [Related]
35. Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman.
Pinto AM; Martins MB; Oliveira N; Oliveira M
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444026
[TBL] [Abstract][Full Text] [Related]
36. A very rare cause of virilization in childhood: ovarian Leydig cell tumor.
Arhan E; Cetinkaya E; Aycan Z; Aslan AT; Yücel H; Vidinlisan S
J Pediatr Endocrinol Metab; 2008 Feb; 21(2):181-3. PubMed ID: 18422031
[TBL] [Abstract][Full Text] [Related]
37. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
[TBL] [Abstract][Full Text] [Related]
38. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
Berbegal L; Albares MP; De-Leon FJ; Negueruela G
Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
[No Abstract] [Full Text] [Related]
39. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
[TBL] [Abstract][Full Text] [Related]
40. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]